Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Aligos Therapeutics Inc

Aligos Therapeutics Inc

ALGS · NASDAQ
ALGS · NASDAQ

Next Earnings: 10 Mar 2025

27.50
USD-1.03-3.61%

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Day Range

25.52USD
28.67USD

52 Week Range

0.35USD
30.43USD

Market Cap

102.86MUSD

About

General Information

Type

Common Stock

Exchange

NASDAQ

Currency Code

USD

Currency Name

US Dollar

Country Name

USA

Country ISO

US

ISIN

US01626L1052

CUSIP

-

Sector

Healthcare

Industry

Biotechnology

Fiscal Year End

December

IPO date

-

Updated At

-

Highlights

PE Ratio

-

PEG Ratio

-

Book Value

15.07

Dividend Share

-

Dividend Yield

-

Earnings Share

-7.25

Wall Street Target Price

103.3333

EPS Estimate Current Year

-10.36

EPS Estimate Next Year

-13.005

EPS Estimate Current Quarter

-2.16

EPS Estimate Next Quarter

-1.49

Most Recent Quarter

-

Profitability

Revenue TTM

5,997,000

Gross Profit TTM

-71,170,000

EBITDA

-92,684,000

Profit Margin

0.00%

Return On Assets TTM

-67.32%

Return On Equity TTM

-146.69%

Revenue Per Share TTM

1.005

Qtly Revenue Growth YOY

-60.80%

Diluted Eps TTM

-7.25

Qtly Earnings Growth YOY

0.00%

Valuation

Trailing PE

0.00

Forward PE

0

Price Sales TTM

16.4886

Price Book MRQ

2.0534

Enterprise Value Revenue

6

Enterprise Value EBITDA

0

Peers analysis

  • CSL Ltd
    CSLLYCSL Ltd

    90.52

    1.02%
  • BeiGene Ltd
    BGNEBeiGene Ltd

    207.25

    0.79%
  • argenx NV ADR
    ARGXargenx NV ADR

    615.60

    0.43%
  • Regeneron Pharmaceuticals Inc
    REGNRegeneron Pharmaceuticals Inc

    786.00

    0.32%
  • Alnylam Pharmaceuticals Inc
    ALNYAlnylam Pharmaceuticals Inc

    256.64

    0.29%
  • BioNTech SE
    BNTXBioNTech SE

    121.20

    0.26%
  • Vertex Pharmaceuticals Inc
    VRTXVertex Pharmaceuticals Inc

    474.30

    0.06%
  • argenx SE
    ARGNFargenx SE

    525.60

    0.00%
  • CSL Limited
    CMXHFCSL Limited

    170.35

    0.00%
  • UCB SA ADR
    UCBJYUCB SA ADR

    96.13

    -1.46%